APA (7th ed.) Citation

Chodak, G. W., Vogelzang, N. J., Caplan, R. J., Soloway, M., & Smith, J. A. (1991). Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. JAMA: Journal of the American Medical Association, 265(5), 618. https://doi.org/10.1001/jama.265.5.618

Chicago Style (17th ed.) Citation

Chodak, G W., N J. Vogelzang, R J. Caplan, M. Soloway, and J A. Smith. "Independent Prognostic Factors in Patients with Metastatic (stage D2) Prostate Cancer. The Zoladex Study Group." JAMA: Journal of the American Medical Association 265, no. 5 (1991): 618. https://doi.org/10.1001/jama.265.5.618.

MLA (9th ed.) Citation

Chodak, G W., et al. "Independent Prognostic Factors in Patients with Metastatic (stage D2) Prostate Cancer. The Zoladex Study Group." JAMA: Journal of the American Medical Association, vol. 265, no. 5, 1991, p. 618, https://doi.org/10.1001/jama.265.5.618.